Alexander Ehrmann
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
-
- Amino Acid Enzymes and Metabolism
Papers in
-
- Sulfur Compounds in Biology 2
-
- Acute Kidney Injury Research 1
- Parathyroid Disorders and Treatments 1
- Co-authors
- Kerstin Unterschemmann (2 shared papers)Michael Haerter (1 shared paper)Iring Heisler (1 shared paper)Peter Ellinghaus (1 shared paper)Susanne Greschat (1 shared paper)Holger Summer (1 shared paper)Karl B. Ziegelbauer (1 shared paper)Hartmut Beck (1 shared paper)
- Journals
- Phytochemistry (1 paper)Nephrology Dialysis Transplantation (1 paper)Frontiers in Pharmacology (1 paper)ACS Medicinal Chemistry Letters (1 paper)Nature Communications (1 paper)
- Partner nations
- GermanyUnited KingdomAustria
In The Last Decade
Alexander Ehrmann
12 papers receiving 417 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 135
- Biochemistry 18
- Oncology 59
- Molecular Biology 162
- Toxicology 10
Countries citing papers authored by Alexander Ehrmann
This map shows the geographic impact of Alexander Ehrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Ehrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Ehrmann more than expected).
Fields of papers citing papers by Alexander Ehrmann
This network shows the impact of papers produced by Alexander Ehrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Ehrmann. The network helps show where Alexander Ehrmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Ehrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 205 | |
| 2 | 2020 | 82 | |
| 3 | 2016 | 49 | |
| 4 | 2009 | 28 | |
| 5 | 2018 | 11 | |
| 6 | 2010 | 10 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2024 | 6 | |
| 11 | 2025 | 6 | |
| 12 | 2026 | 1 |
About Alexander Ehrmann
Alexander Ehrmann is a scholar working on Biochemistry, Nephrology, Molecular Biology, Oncology and Cancer Research, having authored 12 papers that have together received 420 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Sulfur Compounds in Biology (2 papers), Enzyme Structure and Function (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Glutathione Transferases and Polymorphisms (1 paper), Acute Kidney Injury Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Parathyroid Disorders and Treatments (1 paper). The work is most often cited by research in Cancer Research (135 citations), Biochemistry (18 citations), Oncology (59 citations), Molecular Biology (162 citations) and Toxicology (10 citations). Alexander Ehrmann has collaborated with scholars based in Germany, United Kingdom and Austria. Frequent co-authors include Kerstin Unterschemmann, Michael Haerter, Iring Heisler, Peter Ellinghaus, Susanne Greschat, Holger Summer, Karl B. Ziegelbauer, Hartmut Beck, Felix Oehme and Karl‐Heinz Thierauch. Their work appears in journals such as Phytochemistry, Nephrology Dialysis Transplantation, Frontiers in Pharmacology, ACS Medicinal Chemistry Letters and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.